ArticleFrontline gastroenterology2011

Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea.

Mary E Money et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.